From the Department of Emergency Medicine (F.K.K., W.B., W.J.M., H.F.), University of Michigan, Ann Arbor.
Department of Emergency Medicine, Injury Prevention Center (J.G.), University of Michigan, Ann Arbor.
Stroke. 2019 Jul;50(7):1669-1675. doi: 10.1161/STROKEAHA.119.024941. Epub 2019 May 29.
Background and Purpose- Effective stroke prevention depends on accurate stroke risk prediction. We determined the discriminative ability of NfL (neurofilament light chain) levels for distinguishing between adults with diabetes mellitus who develop incident stroke and those who remain stroke free during a 7-year follow-up period. Methods- We performed a case-control study of participants selected from the previously completed ACCORD trial (Action to Control Cardiovascular Risk in Diabetes). Cases were all ACCORD subjects who were stroke free at enrollment and developed incident stroke during follow-up (n=113). Control subjects (n=250) were randomly selected ACCORD subjects who had no stroke events either before or after randomization. NfL was measured in baseline samples using Single Molecule Array technology (Quanterix). Results- Baseline NfL levels were higher in stroke subjects, compared to controls, after adjusting for age, race, blood pressure, weight, and the Framingham Stroke Risk Score. Relative to the subjects in the lowest quintile of NfL levels, the hazard ratios of incident stroke for subjects in the second to fifth quintiles were 3.91 (1.45-10.53), 4.05 (1.52-10.79), 5.63 (2.16-14.66), and 9.75 (3.84-27.71), respectively, after adjusting for race and Framingham Stroke Risk Score. Incorporating NfL levels into a predictive score that already included race and Framingham Stroke Risk Score increased the score's C statistic from 0.71 (95% CI, 0.66-0.77) to 0.78 (95% CI, 0.73-0.83), P<0.001. Older age, nonwhite race, higher systolic blood pressure, glomerular filtration rate <60, and higher hemoglobin A1C were independent predictors of serum NfL in this cohort but diastolic blood pressure, durations of hypertension or diabetes mellitus, and lipid levels were not. In total, cardiovascular disease risk factors explained 19.2% of the variability in baseline NfL levels. Conclusions- Serum NfL levels predict incident stroke and add considerably to the discriminatory power of the Framingham Stroke Risk Score in a cohort of middle-aged and older adults with diabetes mellitus.
背景与目的-有效的卒中预防取决于准确的卒中风险预测。我们确定了神经丝轻链(NfL)水平在区分患有糖尿病的成年人中,在 7 年随访期间发生卒中的患者与未发生卒中的患者的能力。方法-我们进行了一项病例对照研究,研究对象选自先前完成的 ACCORD 试验(控制心血管风险行动中的糖尿病)。病例均为 ACCORD 受试者,在入组时无卒中,在随访期间发生了卒中事件(n=113)。对照(n=250)是随机选择的 ACCORD 受试者,他们在随机分组前后均无卒中事件。使用单分子阵列技术(Quanterix)在基线样本中测量 NfL。结果-调整年龄、种族、血压、体重和弗雷明汉卒中风险评分后,与对照组相比,卒中组的基线 NfL 水平更高。与 NfL 水平最低五分位数的受试者相比,第二至五分位数的受试者发生卒中的风险比分别为 3.91(1.45-10.53)、4.05(1.52-10.79)、5.63(2.16-14.66)和 9.75(3.84-27.71),调整种族和弗雷明汉卒中风险评分后。将 NfL 水平纳入已包含种族和弗雷明汉卒中风险评分的预测评分中,使评分的 C 统计量从 0.71(95%CI,0.66-0.77)增加到 0.78(95%CI,0.73-0.83),P<0.001。在该队列中,年龄较大、非白种人、较高的收缩压、肾小球滤过率<60 和较高的糖化血红蛋白是血清 NfL 的独立预测因子,但舒张压、高血压或糖尿病的持续时间和血脂水平不是。总的来说,心血管疾病危险因素解释了基线 NfL 水平变异的 19.2%。结论-血清 NfL 水平可预测卒中事件,并在患有糖尿病的中老年人群中显著增加弗雷明汉卒中风险评分的区分能力。